Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026Accesswire • 01/13/26
Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York CityAccesswire • 01/12/26
Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in AdultsAccesswire • 12/15/25
Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity ConferenceAccesswire • 11/24/25
Aytu BioPharma Inc. (AYTU) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 11/13/25
Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial ResultsAccesswire • 11/13/25
Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025Accesswire • 11/05/25
Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)Accesswire • 09/23/25
Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025Accesswire • 09/16/25
Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)Accesswire • 06/25/25
Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)Accesswire • 06/23/25
Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization PlanAccesswire • 06/09/25
Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common StockAccesswire • 06/06/25
Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United StatesAccesswire • 06/06/25